Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art

24Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications.

Cite

CITATION STYLE

APA

Páez-Carpio, A., Gómez, F. M., Isus Olivé, G., Paredes, P., Baetens, T., Carrero, E., … Vollmer, I. (2021, December 1). Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art. Insights into Imaging. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1186/s13244-021-00997-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free